Amgen Stock Analysis (NASDAQ:AMGN)

Add to My Stocks
$164.71 $0.2 (0.12%) AMGN stock closing price Mar 28, 2017 (Closing)
Watch Robo Advisor Video of AMGN Stock Analysis
Amgen
Updated on : Mar 28, 2017
previous close
AMGN 164.7 (0%)
S&P 500 2358.6 (0%)
Closing Price On: Mar 28, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Biomed-Genetics
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q4
$billion
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
42.6%
Sector Average:
-6.4%
5 Quarter Net Profit
Net Margins
2016-Q4
%
LTM Margin
Compared to the industry
Debt/Equity Ratio
Debt:
34.6B
Debt/Equity Ratio:
 1.16
Compared to the industry
Cash Flow
Operating cash flow:
$3.1B
Net Income:
$1.94B
Dividend Yield
AMGN dividend yield:
2.43%
PROS      CONS
Operating Margins
Net Margins
Cash Flow
ROIC
ROE
FCF Margin
High Debt Burden
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
AMGN PS :
5.3
Industry PS :
4.7
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
26.1%
Return on Equity:
26.2%
Free Cash Flow Margin:
49.2%
Double Tap To Exit Full Screen
0:00
/

Amgen Analysis Video

955 5 3 1

View Amgen stock analysis video. This is our AMGN analyst opinion covering the buy and sell arguments for AMGN stock.

Amgen, Inc. Stock Rating (4.3/5)

Our Amgen stock opinion is based on fundamentals of the company. This Amgen stock analysis is based on latest Q4 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy AMGN stock?

  • The TTM operating margin was good at 42.6% for Amgen.
  • LTM Net margins were good at 33.6% for Amgen.
  • The operating cash flow looks good at 1.6 times the net income.
  • The Amgen stock currently trades at a price to earnings ratio of 14.1. We rate this as a positive, compared to the industry average of 21.2.
  • Amgen has an attractive ROIC (Return on Invested Capital) of 26.1%
  • Amgen has a good Return On Equity (ROE) of 26.2%.
  • Amgen has a healthy FCF (Free Cash Flow) margin of 49.2%.

Should you sell AMGN stock?

  • Amgen has a debt/equity ratio of  1.16, which is worse than the average in the Medical sector.

Comments on this video and Amgen stock

tavern123 on Amgen stock analysis ($148.69)
bullish
The stock is relatively cheap. It deserves another look. If "what goes up, must come down", then "what is down, should go up"!
reply